These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19065061)

  • 1. Irbesartan ameliorates diabetic nephropathy by reducing the expression of connective tissue growth factor and alpha-smooth-muscle actin in the tubulointerstitium of diabetic rats.
    Ren X; Guan G; Liu G; Liu G
    Pharmacology; 2009; 83(2):80-7. PubMed ID: 19065061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats].
    Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ
    Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
    Anjaneyulu M; Chopra K
    Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats.
    Liu BC; Chen Q; Luo DD; Sun J; Phillips AO; Ruan XZ; Liu NF
    Acta Pharmacol Sin; 2003 Jan; 24(1):67-73. PubMed ID: 12511232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
    Lai PB; Zhang L; Yang LY
    Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy.
    Sen S; Kanter M; Ustundag S; Aktas C; Dogutan H; Yalcin O
    Ren Fail; 2008; 30(10):1023-33. PubMed ID: 19016156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of simvastatin on expression of CTGF and α-SMA in renal tubulointerstitium of rats with diabetic nephropathy].
    Lin FL; Shen HC; Zhu B; Lin KQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 39(5):511-6. PubMed ID: 20936727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Triptolide combined with irbesartan synergistically blocks podocyte injury in a type 2 diabetes rat model].
    Ma RX; Xu Y; Zhang J; Li YS; Liu LQ
    Zhonghua Nei Ke Za Zhi; 2012 Feb; 51(2):117-22. PubMed ID: 22490812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
    Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of tripterygium wilfordii polyglucoside on expression of Activin A and influence of transdifferentiation in renal tubulointerstitium of rats with diabetic nephropathy].
    Zhao C; Yu W; Ren X; Zhang W; Li H
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(18):1427-32. PubMed ID: 25142998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the Ku70 and apoptosis-related proteins in experimental diabetic nephropathy.
    Tunçdemir M; Öztürk M
    Metabolism; 2016 Oct; 65(10):1466-77. PubMed ID: 27621182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connective tissue growth factor-mediated angiotensin II-induced hypertrophy of proximal tubular cells.
    Liu BC; Chen L; Sun J; Huang HQ; Ma KL; Liu H; Liu DG; Zhang XL
    Nephron Exp Nephrol; 2006; 103(1):e16-26. PubMed ID: 16374037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of irbesartan on renal advanced glycation end products and their receptor in rats with early diabetic nephropathy].
    Long HB; Niu HX; Li XY; Zhou WD; He JH; Zhong J; Wei LB
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2433-6, 2441. PubMed ID: 20034895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal protection by low dose irbesartan in diabetic nephropathy is paralleled by a reduction of inflammation, not of endoplasmic reticulum stress.
    Hartner A; Cordasic N; Klanke B; Menendez-Castro C; Veelken R; Schmieder RE; Hilgers KF
    Biochim Biophys Acta; 2014 Apr; 1842(4):558-65. PubMed ID: 24418215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
    Yu WM; Wang H; Ren XJ; Liu JP; Wang JY
    Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy.
    Vieitez P; Gómez O; Uceda ER; Vera ME; Molina-Holgado E
    J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):96-102. PubMed ID: 18584585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin II receptor blocker on myocardial endothelial-to-mesenchymal transition in diabetic rats.
    Tang RN; Lv LL; Zhang JD; Dai HY; Li Q; Zheng M; Ni J; Ma KL; Liu BC
    Int J Cardiol; 2013 Jan; 162(2):92-9. PubMed ID: 21704391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of irbesartan on expression of ILK and its relationship with epithelial-mesenchymal transition in mice with unilateral ureteral obstruction.
    Liu BC; Xia HL; Wu JN; Zhang XL; Liu DG; Gong YX
    Acta Pharmacol Sin; 2007 Nov; 28(11):1810-8. PubMed ID: 17959033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
    Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
    Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats.
    Janiak P; Bidouard JP; Cadrouvele C; Poirier B; Gouraud L; Grataloup Y; Pierre F; Bruneval P; O'Connor SE; Herbert JM
    Eur J Pharmacol; 2006 Mar; 534(1-3):271-9. PubMed ID: 16516882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.